These results suggest that CAR-NK cells could be a better approach than CAR T cells for treatment of OC because of their specific characteristics, as they cause less systemic toxicity due to the absence of IL-6 secretion, which may avoid CRS. This evidence concerns the gene IL6 and congenital rubella syndrome.